title: Transcriptional pathways and potential therapeutic targets in the regulation of Ncx1 expression in cardiac hypertrophy and failure.
abstract: Changes in cardiac gene expression contribute to the progression of heart failure by affecting cardiomyocyte growth, function, and survival. The Na(+)-Ca(2+) exchanger gene (Ncx1) is upregulated in hypertrophy and is often found elevated in end-stage heart failure. Studies have shown that the change in its expression contributes to contractile dysfunction. Several transcriptional pathways mediate Ncx1 expression in pathological cardiac remodeling. Both α-adrenergic receptor (α-AR) and β-adrenergic receptor (β-AR) signaling can play a role in the regulation of calcium homeostasis in the cardiomyocyte, but chronic activation in periods of cardiac stress contributes to heart failure by mechanisms which include Ncx1 upregulation. Our studies have even demonstrated that NCX1 can directly act as a regulator of "activity-dependent signal transduction" mediating changes in its own expression. Finally, we present evidence that histone deacetylases (HDACs) and histone acetyltransferases (HATs) act as master regulators of Ncx1 expression. We show that many of the transcription factors regulating Ncx1 expression are important in cardiac development and also in the regulation of many other genes in the so-called fetal gene program, which are activated by pathological stimuli. Importantly, studies have revealed that the transcriptional network regulating Ncx1 expression is also mediating many of the other changes in genetic remodeling contributing to the development of cardiac dysfunction and revealed potential therapeutic targets for the treatment of hypertrophy and failure.
authors.affiliation: Department of Medicine, Gazes Cardiac Research Institute, Medical University of South Carolina, Charleston, SC 29425, USA. menickd@musc.edu
authors.forename: Donald R
authors.initials: DR
authors.lastname: Menick
authors.forename: Mona S
authors.initials: MS
authors.lastname: Li
authors.forename: Olga
authors.initials: O
authors.lastname: Chernysh
authors.forename: Ludivine
authors.initials: L
authors.lastname: Renaud
authors.forename: Denise
authors.initials: D
authors.lastname: Kimbrough
authors.forename: Harinath
authors.initials: H
authors.lastname: Kasiganesan
authors.forename: Santhosh K
authors.initials: SK
authors.lastname: Mani
mesh_terms: D000818:Animals; D002118:Calcium / Q000378:metabolism; D006332:Cardiomegaly / Q000235:genetics / Q000378:metabolism* / Q000473:pathology / Q000628:therapy; D005786:Gene Expression Regulation; D006333:Heart Failure / Q000235:genetics / Q000378:metabolism* / Q000473:pathology / Q000628:therapy; D051548:Histone Acetyltransferases / Q000235:genetics / Q000378:metabolism; D006655:Histone Deacetylases / Q000235:genetics / Q000378:metabolism; D006801:Humans; D009124:Muscle Proteins / Q000096:biosynthesis* / Q000235:genetics; D009200:Myocardial Contraction / Q000235:genetics; D011942:Receptors, Adrenergic, alpha / Q000235:genetics / Q000378:metabolism; D011943:Receptors, Adrenergic, beta / Q000235:genetics / Q000378:metabolism; D019831:Sodium-Calcium Exchanger / Q000096:biosynthesis* / Q000235:genetics; D014158:Transcription, Genetic
chemical_list: D009124:Muscle Proteins; D011942:Receptors, Adrenergic, alpha; D011943:Receptors, Adrenergic, beta; D019831:Sodium-Calcium Exchanger; C110374:sodium-calcium exchanger 1; D051548:Histone Acetyltransferases; D006655:Histone Deacetylases; D002118:Calcium